Baba, Vevencio, JR.. S.

HRN: 14-66-82  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/01/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/02/2023
06/08/2023
IVTT
2.25 G
Q6
CapHR; (antibiotic Extension)
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: